Platelets as immune cells in infectious diseases.
暂无分享,去创建一个
Cornelia Lass-Flörl | Sven Krappmann | Jürgen Löffler | J. Löffler | S. Krappmann | C. Lass‐Flörl | C. Speth | G. Rambach | Cornelia Speth | Günter Rambach
[1] P. Hundelshausen,et al. Platelets in atherosclerosis , 2011, Thrombosis and Haemostasis.
[2] J. Pontón,et al. Binding of resting platelets to Candida albicans germ tubes , 1996, Infection and immunity.
[3] A. Kirk,et al. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. , 2005, Experimental hematology.
[4] J. Hartwig,et al. Cytoskeletal mechanics of proplatelet maturation and platelet release , 2010, The Journal of cell biology.
[5] W. Ouwehand,et al. Hepatitis C virus interacts with human platelet glycoprotein VI. , 2006, The Journal of general virology.
[6] E. Antunes,et al. Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation , 2012, Platelets.
[7] L. Leibovici,et al. Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. , 2011, Mayo Clinic proceedings.
[8] J. Wiesner,et al. Antimicrobial peptides: The ancient arm of the human immune system , 2010, Virulence.
[9] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[10] J. Qiao,et al. ITAM receptor‐mediated generation of reactive oxygen species in human platelets occurs via Syk‐dependent and Syk‐independent pathways , 2012, Journal of thrombosis and haemostasis : JTH.
[11] P. Chien,et al. Platelet FcγRIIA binds and internalizes IgG-containing complexes , 2006 .
[12] M. Selsted,et al. Antimicrobial Peptides from Human Platelets , 2002, Infection and Immunity.
[13] M. Fukata,et al. Role of elevated platelet‐associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases , 2003, Journal of gastroenterology and hepatology.
[14] T. van der Poll,et al. Tissue factor in infection and severe inflammation. , 2006, Seminars in thrombosis and hemostasis.
[15] Z. Ruggeri,et al. The role of von Willebrand factor in thrombus formation. , 2007, Thrombosis research.
[16] Simon,et al. Human platelet inhibition of Toxoplasma gondii growth , 1998, Clinical and experimental immunology.
[17] Zongdong Li,et al. The inhibition effect of anti-GPIIIa49–66 antibody on megakaryocyte differentiation , 2011, Thrombosis and Haemostasis.
[18] A. Nurden. Platelets, inflammation and tissue regeneration , 2011, Thrombosis and Haemostasis.
[19] E. Chi,et al. Cytotoxic activity of 13-hydroxyoctadecadienoic acid against Toxoplasma gondii , 1992, Parasitology.
[20] J. Michel,et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options , 2012, Thrombosis and Haemostasis.
[21] D. Prockop,et al. Human immunodeficiency virus type 1 Vpr alters bone marrow cell function. , 1999, Blood.
[22] J. Cowland,et al. Neutrophil granules in health and disease , 2010, Journal of internal medicine.
[23] S. Meshnick,et al. Hematologic and clinical indices of malaria in a semi-immune population of western Thailand. , 2004, The American journal of tropical medicine and hygiene.
[24] M. Ghannoum,et al. Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis , 1996, Infection and immunity.
[25] A. Cheung,et al. The Staphylococcus aureus Two-Component Regulatory System, GraRS, Senses and Confers Resistance to Selected Cationic Antimicrobial Peptides , 2011, Infection and Immunity.
[26] B. Polack,et al. Platelet cytotoxicity against parasites. , 1991, Nouvelle revue francaise d'hematologie.
[27] S. Goto,et al. Platelets, after Exposure to a High Shear Stress, Induce IL-10-Producing, Mature Dendritic Cells In Vitro1 , 2004, The Journal of Immunology.
[28] S. Ferreira,et al. Inhibition of the Ecto-ATPdiphosphohydrolase of Schistosoma mansoni by Thapsigargin , 2000, Bioscience reports.
[29] W. Yin,et al. Complement activation on platelets: implications for vascular inflammation and thrombosis. , 2010, Molecular immunology.
[30] M. Yeaman. Platelets in defense against bacterial pathogens , 2009, Cellular and Molecular Life Sciences.
[31] S. Watson,et al. Glycoprotein Ibα and FcγRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis , 2013, Journal of thrombosis and haemostasis : JTH.
[32] G. Kovacs,et al. Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis , 2012, Annals of clinical biochemistry.
[33] R. Koenen,et al. Platelet‐Mediated Enhancement of Leukocyte Adhesion , 2009, Microcirculation.
[34] F. Natividad,et al. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. , 2012, The Journal of infectious diseases.
[35] Reinhold Förster,et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.
[36] O. Garraud,et al. Platelet Toll-like receptor expression: the link between "danger" ligands and inflammation. , 2010, Inflammation & allergy drug targets.
[37] W. Baldwin,et al. Platelets Present Antigen in the Context of MHC Class I , 2012, The Journal of Immunology.
[38] S. Frøland,et al. Activation of Platelets by Aspergillus fumigatus and Potential Role of Platelets in the Immunopathogenesis of Aspergillosis , 2009, Infection and Immunity.
[39] A. Bayer,et al. Plasmid-Mediated Resistance to Thrombin-Induced Platelet Microbicidal Protein in Staphylococci: Role of theqacA Locus , 1999, Antimicrobial Agents and Chemotherapy.
[40] A. Peschel,et al. Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin , 2001, Peptides.
[41] L. Adinolfi,et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis , 2001, British journal of haematology.
[42] J. Freedman,et al. Platelets and the immune continuum , 2011, Nature Reviews Immunology.
[43] M. Doenhoff,et al. Platelets as an innate defence mechanism against Schistosoma mansoni infections in mice , 2003, Parasite immunology.
[44] M. Mori,et al. Thrombocytopenia associated with hepatitis C viral infection. , 1996, Journal of hepatology.
[45] E. Anaissie,et al. Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] R. Flaumenhaft,et al. T granules in human platelets function in TLR9 organization and signaling , 2012, The Journal of cell biology.
[47] M. Peck‐Radosavljevic. Thrombocytopenia in liver disease. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[48] R. Mortara,et al. Molecular characterization and immunolocalization of Schistosoma mansoni ATP-diphosphohydrolase. , 2003, Biochemical and biophysical research communications.
[49] P. Nilsson,et al. Platelets, complement, and contact activation: partners in inflammation and thrombosis. , 2012, Advances in experimental medicine and biology.
[50] C. Atreya,et al. Antiviral activity of selected antimicrobial peptides against vaccinia virus☆ , 2010, Antiviral Research.
[51] A. Kirk,et al. Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. , 2004, Experimental hematology.
[52] A. Weyrich,et al. Platelets: signaling cells in the immune continuum. , 2004, Trends in immunology.
[53] H. Kemona,et al. Activation of blood platelets in echinococcosis — CD62P and CD63 expression , 2006, Parasitology Research.
[54] J. Latgé,et al. Production of Extracellular Traps against Aspergillus fumigatus In Vitro and in Infected Lung Tissue Is Dependent on Invading Neutrophils and Influenced by Hydrophobin RodA , 2010, PLoS pathogens.
[55] Christian Weber,et al. Platelet Microparticles: A Transcellular Delivery System for RANTES Promoting Monocyte Recruitment on Endothelium , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[56] C. Smith,et al. Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. , 2011, American journal of physiology. Heart and circulatory physiology.
[57] S. Zakynthinos,et al. Coagulation system and platelets are fully activated in uncomplicated sepsis , 2000, Critical care medicine.
[58] K. Jurk,et al. Platelets at the Interface between Hemostasis and Innate Immunity , 2004, Transfusion Medicine and Hemotherapy.
[59] J. Krijgsveld,et al. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. , 2001, The Journal of infectious diseases.
[60] J. Hartwig,et al. Blood Platelets Are Assembled Principally at the Ends of Proplatelet Processes Produced by Differentiated Megakaryocytes , 1999, The Journal of cell biology.
[61] T. Ratliff,et al. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. , 2008, Blood.
[62] D. Stevens,et al. Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. , 2005, The Journal of infectious diseases.
[63] S. Watson,et al. Platelets and the innate immune system: mechanisms of bacterial‐induced platelet activation , 2011, Journal of thrombosis and haemostasis : JTH.
[64] J. White,et al. Effects of large latex particle uptake of the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. , 1981, Ultrastructural pathology.
[65] B. Lowe,et al. Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome , 2002, British journal of haematology.
[66] B. Herndon,et al. Platelet depletion and severity of streptococcal endocarditis. , 1998, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[67] W. DeGrado,et al. Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials. , 2012, Cell host & microbe.
[68] S. Thota,et al. Immune thrombocytopenia in adults: An update , 2012, Cleveland Clinic Journal of Medicine.
[69] M. Ghannoum,et al. Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro , 1994, Antimicrobial Agents and Chemotherapy.
[70] M. Dierich,et al. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro. , 2004, International journal of antimicrobial agents.
[71] R. Calderone,et al. Platelet interactions with Candida albicans , 1981, Infection and immunity.
[72] N. Maugeri,et al. Dangerous connections: neutrophils and the phagocytic clearance of activated platelets , 2010, Current opinion in hematology.
[73] H. Liebman. Other immune thrombocytopenias. , 2007, Seminars in hematology.
[74] J. Potempa,et al. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. , 2001, Blood.
[75] Robert A. Campbell,et al. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. , 2012, Blood.
[76] Stephen R. Clark,et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.
[77] R. Flaumenhaft,et al. Platelet alpha-granules: basic biology and clinical correlates. , 2009, Blood reviews.
[78] C. Facer,et al. Elevated Plasma Levels of P‐Selectin (GMP‐140/CD62P) in Patients with Plasmodium falciparum Malaria , 1994, Microbiology and immunology.
[79] S. Foote,et al. Platelet Factor 4 and Duffy Antigen Required for Platelet Killing of Plasmodium falciparum , 2012, Science.
[80] W. Borkowsky,et al. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. , 2008, Blood.
[81] T. Hohl,et al. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. , 2009, The Journal of infectious diseases.
[82] G. Grau,et al. Platelets Potentiate Brain Endothelial Alterations Induced by Plasmodium falciparum , 2006, Infection and Immunity.
[83] G. Davı̀,et al. Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.
[84] A. Fuse,et al. HIV Infection of Megakaryocytic Cell Lines , 2000, Leukemia & lymphoma.
[85] B. Nieswandt,et al. Cooperation between platelet‐derived CD154 and CD4+ T cells for enhanced germinal center formation , 2005, Journal of leukocyte biology.
[86] P. Münzer,et al. Stimulation of platelet apoptosis by peptidoglycan from Staphylococcus aureus 113 , 2012, Apoptosis.
[87] R. Calderone,et al. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro , 1980, Infection and immunity.
[88] C. Esmon. Molecular circuits in thrombosis and inflammation , 2013, Thrombosis and Haemostasis.
[89] G. Kouraklis,et al. Immunological HCV-Associated Thrombocytopenia: Short Review , 2012, Clinical & developmental immunology.
[90] T. Foster,et al. Elucidating the role of Staphylococcus epidermidis serine–aspartate repeat protein G in platelet activation , 2009, Journal of thrombosis and haemostasis : JTH.
[91] R. Calderone,et al. Role of surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro , 1981, Infection and immunity.
[92] T. Fujita,et al. Analysis of C5a receptor by monoclonal antibody. , 1995, Journal of immunological methods.
[93] S. Tsuji,et al. Platelet Shape Changes and Adhesion Under High Shear Flow , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[94] Andreas Peschel,et al. How do bacteria resist human antimicrobial peptides? , 2002, Trends in microbiology.
[95] A. Bayer,et al. Susceptibility to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Increased Fluconazole Efficacy against Experimental Endocarditis Due to Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.
[96] C. Gleissner,et al. Platelet Chemokines in Vascular Disease , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[97] G. Smyth,et al. Platelets Kill Intraerythrocytic Malarial Parasites and Mediate Survival to Infection , 2009, Science.
[98] W. Gahl,et al. Molecular defects that affect platelet dense granules. , 2004, Seminars in thrombosis and hemostasis.
[99] A. Fauci,et al. Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor , 2012, Proceedings of the National Academy of Sciences.
[100] J. Maciejewski,et al. In vitro infection of megakaryocytes and their precursors by human cytomegalovirus. , 2000, Blood.
[101] W. Burgstaller,et al. Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. , 2007, International journal of antimicrobial agents.
[102] R. Robert,et al. Adherence of Platelets to CandidaSpecies In Vivo , 2000, Infection and Immunity.
[103] M. Ghannoum,et al. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro , 1993, Antimicrobial Agents and Chemotherapy.
[104] A. Cheung,et al. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins , 1997, Infection and immunity.
[105] Gemma L. J. Fuller,et al. DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by Platelets , 2006, Journal of Virology.
[106] C. Lass‐Flörl,et al. Candida albicans and its metabolite gliotoxin inhibit platelet function via interaction with thiols , 2010, Thrombosis and Haemostasis.
[107] J. Kos,et al. Iron‐regulated surface determinant B (IsdB) promotes Staphylococcus aureus adherence to and internalization by non‐phagocytic human cells , 2013, Cellular microbiology.
[108] P. Kubes,et al. Platelets: bridging hemostasis, inflammation, and immunity , 2013, International journal of laboratory hematology.
[109] A. Zychlinsky,et al. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms , 2006, Cellular microbiology.
[110] D. Cines,et al. Pathobiology of Secondary Immune Thrombocytopenia , 2009, Seminars in Hematology.
[111] E. Peerschke,et al. Human blood platelet gC1qR/p33 , 2001, Immunological reviews.
[112] Yee‐Shin Lin,et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis , 2011, Experimental biology and medicine.
[113] S. Smyth,et al. Platelets as immune mediators: their role in host defense responses and sepsis. , 2011, Thrombosis research.
[114] White Jg,et al. Effects of small latex particle uptake on the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. , 1982 .
[115] R. Würzner,et al. Complement: an efficient sword of innate immunity. , 2008, Contributions to microbiology.
[116] M. Ernst,et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. , 2000, Blood.
[117] H. Kemona,et al. [The secretory activity of blood platelets--beta-thromboglobulin and platelet factor 4 in echinococcosis]. , 2005, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[118] M. Baggiolini,et al. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. , 2000, Blood.
[119] E. Chi,et al. Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane , 1991, The Journal of experimental medicine.
[120] R. Darouiche,et al. Sepsis syndrome, bloodstream infections, and device-related infections. , 2012, The Medical clinics of North America.
[121] S. Horie,et al. Effect of CAWS, a mannoprotein-beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. , 2003, Biological & pharmaceutical bulletin.
[122] H. Schild,et al. TREM-1 ligand expression on platelets enhances neutrophil activation. , 2007, Blood.
[123] Shuying Wang,et al. Autoimmunity in dengue pathogenesis. , 2013, Journal of the Formosan Medical Association = Taiwan yi zhi.
[124] C. Shun,et al. Platelets enhance biofilm formation and resistance of endocarditis-inducing streptococci on the injured heart valve. , 2012, The Journal of infectious diseases.
[125] W. Yin,et al. Blood platelets activate the classical pathway of human complement , 2006, Journal of thrombosis and haemostasis : JTH.
[126] Robert A. Campbell,et al. Novel Anti-bacterial Activities of β-defensin 1 in Human Platelets: Suppression of Pathogen Growth and Signaling of Neutrophil Extracellular Trap Formation , 2011, PLoS pathogens.
[127] J. Freedman,et al. Platelets and innate immunity , 2010, Cellular and Molecular Life Sciences.
[128] B. Hausott,et al. Interaction of Platelets and Anidulafungin against Aspergillus fumigatus , 2012, Antimicrobial Agents and Chemotherapy.
[129] J. Bae,et al. Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC. , 2004, Cytotherapy.
[130] J. Krijgsveld,et al. Thrombocidins, Microbicidal Proteins from Human Blood Platelets, Are C-terminal Deletion Products of CXC Chemokines* , 2000, The Journal of Biological Chemistry.
[131] G. Martin. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes , 2012, Expert review of anti-infective therapy.
[132] A. Antczak,et al. Internalization of IgG-Coated Targets Results in Activation and Secretion of Soluble CD40 Ligand and RANTES by Human Platelets , 2010, Clinical and Vaccine Immunology.
[133] R. Aster. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. , 1966, The Journal of clinical investigation.
[134] Hisham S. Elbatarny,et al. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. , 2007, Blood.
[135] H. Vogel,et al. Native Thrombocidin-1 and Unfolded Thrombocidin-1 Exert Antimicrobial Activity via Distinct Structural Elements , 2011, The Journal of Biological Chemistry.
[136] C. Rogier,et al. Prognostic value of thrombocytopenia in African children with falciparum malaria. , 2002, The American journal of tropical medicine and hygiene.
[137] G. Cagney,et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.
[138] Hui Zhang,et al. Platelet activation leads to activation and propagation of the complement system , 2005, The Journal of experimental medicine.
[139] D. Phillips,et al. Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions. , 1998, Archives of pathology & laboratory medicine.
[140] C. Spada,et al. An Overview of the Mechanisms of HIV-Related Thrombocytopenia , 2010, Acta Haematologica.
[141] A. Emeribe,et al. In vivo platelet aggregation in acute malaria. , 1991, Acta tropica.
[142] A. Dubart-Kupperschmitt,et al. Lentivirus degradation and DC‐SIGN expression by human platelets and megakaryocytes , 2006, Journal of thrombosis and haemostasis : JTH.
[143] M. Yeaman,et al. Peptide antimicrobials: cell wall as a bacterial target , 2013, Annals of the New York Academy of Sciences.
[144] J. Heesemann,et al. NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. , 2010, Microbes and infection.
[145] M. Sticherling,et al. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. , 1995, International archives of allergy and immunology.
[146] K. Zen,et al. Down-Regulation of Platelet Surface CD47 Expression in Escherichia coli O157:H7 Infection-Induced Thrombocytopenia , 2009, PloS one.
[147] S. Galdino,et al. The evolution of drugs on schistosoma treatment: looking to the past to improve the future. , 2013, Mini reviews in medicinal chemistry.
[148] A. Kaye. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. , 2011, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.
[149] M. Dierich,et al. Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus. , 2010, The Journal of antimicrobial chemotherapy.
[150] R. Testa,et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. , 2002, Journal of hepatology.
[151] S Bhakdi,et al. Alpha-toxin of Staphylococcus aureus. , 1991, Microbiological reviews.
[152] E. Lampe,et al. Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study , 2004, Annals of Hematology.
[153] E. Lampe,et al. Autoimmune thrombocytopenia related to chronic hepatitis C virus infection , 2009, Hematology.
[154] W. Mayr,et al. Plasmodium falciparum malaria and the immunogenetics of ABO, HLA, and CD36 (platelet glycoprotein IV) , 2011, Vox sanguinis.
[155] M. Molyneux,et al. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. , 2003, The Journal of infectious diseases.
[156] A. Weyrich,et al. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC‐SIGN and caspases , 2013, Journal of thrombosis and haemostasis : JTH.
[157] K. Ley,et al. Platelet-neutrophil-interactions: linking hemostasis and inflammation. , 2007, Blood reviews.
[158] M. Dierich,et al. Potential antifungal effects of human platelets against zygomycetes in vitro. , 2009, The Journal of infectious diseases.
[159] M. Molyneux,et al. Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria-possible modulation in vivo by thrombocytopenia. , 2008, The Journal of infectious diseases.
[160] M. Brambilla,et al. A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? , 1995, Clinical and experimental rheumatology.
[161] A. Capron,et al. A new function for platelets: IgE-dependent killing of schistosomes , 1983, Nature.
[162] Zhen-yu Huang,et al. Human platelet FcγRIIA and phagocytes in immune-complex clearance. , 2011, Molecular immunology.
[163] L. O’Neill,et al. How Toll-like receptors signal: what we know and what we don't know. , 2006, Current opinion in immunology.
[164] P. Hjemdahl,et al. Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans , 2011, Thrombosis and Haemostasis.
[165] J. Freedman,et al. Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase , 2009, Circulation research.
[166] J. Decruyenaere,et al. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. , 2010, Heart & lung : the journal of critical care.
[167] S. Klotz,et al. Aggregated platelets enhance adherence of Candida yeasts to endothelium. , 1989, The Journal of infectious diseases.
[168] O. Yamada,et al. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon‐α therapy: possible etiology of HCV‐associated immune thrombocytopenia , 2005, European journal of haematology.
[169] P. Płonka,et al. Platelets augment respiratory burst in neutrophils activated by selected species of gram-positive or gram-negative bacteria. , 2008, Folia histochemica et cytobiologica.
[170] B. B. Weksler. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease , 2007, Alimentary pharmacology & therapeutics.
[171] P. Nurden,et al. Platelet-associated CD154 in immune thrombocytopenic purpura. , 2005, Blood.
[172] C. Sprung,et al. Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.
[173] A. Bayer,et al. In Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Enhanced Progression and Hematogenous Dissemination in Experimental Staphylococcus aureusInfective Endocarditis , 1998, Infection and Immunity.
[174] D. Fearon,et al. Cellular distribution of complement receptor type 4 (CR4): expression on human platelets. , 1987, Journal of immunology.
[175] B. Davidson,et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. , 2003, Immunity.
[176] R. Würzner,et al. Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds. , 2013, The Journal of infectious diseases.
[177] Tomoki Ito,et al. Platelet-derived microparticles cause CD154-dependent activation of dendritic cells , 2012, Platelets.
[178] D. Rotrosen,et al. Adherence of Candida species to host tissues and plastic surfaces. , 1986, Reviews of infectious diseases.
[179] A. Weyrich,et al. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. , 2009, American journal of respiratory cell and molecular biology.
[180] D. Cox,et al. The role of platelets in the pathogenesis of cerebral malaria , 2010, Cellular and Molecular Life Sciences.
[181] L. Cosgrove,et al. CR3 receptor on platelets and its role in the prostaglandin metabolic pathway , 1987, Immunology and cell biology.
[182] A. Maseri,et al. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. , 2009, Blood.
[183] T. Meshulam,et al. Human Platelets Damage Aspergillus fumigatus Hyphae and May Supplement Killing by Neutrophils , 1998, Infection and Immunity.
[184] M. A. van de Laar,et al. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. , 2002, Arthritis and rheumatism.
[185] J. Freedman,et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. , 2006, Blood.
[186] J. Allain,et al. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. , 2001, Blood.
[187] M. Klinger,et al. The blood platelets contribution to innate host defense – What they have learned from their big brothers , 2009, Biotechnology journal.
[188] M. Gawaz,et al. Platelet-monocyte interactions--a dangerous liaison linking thrombosis, inflammation and atherosclerosis. , 2008, Current medicinal chemistry.
[189] S. Niranjan,et al. Thrombocytopenia in malaria. , 2004, Journal of the National Medical Association.
[190] B. Binder,et al. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2 , 2011, Journal of thrombosis and haemostasis : JTH.
[191] R. Würzner,et al. Complement in typical hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.
[192] Nina Singh,et al. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. , 2000, Transplantation.
[193] C. T. Ammollo,et al. Sepsis, thrombosis and organ dysfunction. , 2012, Thrombosis research.
[194] T. J. Neiva,et al. Effect of pathogenic yeasts on human platelet aggregation , 2003 .
[195] M. Dierich,et al. Human platelets attenuate Aspergillus species via granule-dependent mechanisms. , 2008, The Journal of infectious diseases.
[196] C. Flaujac,et al. Platelets and viruses: an ambivalent relationship , 2010, Cellular and Molecular Life Sciences.
[197] Christian Weber,et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. , 2005, Blood.
[198] Florea Lupu,et al. Differential regulation of human and murine P-selectin expression and function in vivo , 2010, The Journal of experimental medicine.
[199] P. Théroux,et al. Requirements for Membrane Attack Complex Formation and Anaphylatoxins Binding to Collagen-Activated Platelets , 2011, PloS one.
[200] B. C. Webb,et al. Interactions between Candida species and platelets. , 1998, Journal of medical microbiology.
[201] M. Ratajczak,et al. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co‐receptor CXCR4 on their surface: determination of response to stromal‐derived factor‐1 by megakaryocytes and platelets , 1999, British journal of haematology.
[202] R. Andriantsitohaina,et al. Microparticles as regulators of cardiovascular inflammation. , 2012, Trends in cardiovascular medicine.
[203] J. Wang,et al. HIV‐1 Tat‐induced platelet activation and release of CD154 contribute to HIV‐1‐associated autoimmune thrombocytopenia , 2011, Journal of thrombosis and haemostasis : JTH.
[204] E. Cramer,et al. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. , 2002, Blood.
[205] H. Isomura,et al. Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro. , 2000, The Journal of general virology.
[206] R. Frade,et al. Activation of human platelets through gp140, the C3d/EBV receptor (CR2) , 1987, European journal of immunology.
[207] K. Jurk,et al. Platelets: Physiology and Biochemistry , 2005, Seminars in thrombosis and hemostasis.
[208] F. Petersen,et al. Platelet Factor 4 (CXC Chemokine Ligand 4) Differentially Regulates Respiratory Burst, Survival, and Cytokine Expression of Human Monocytes by Using Distinct Signaling Pathways1 , 2007, The Journal of Immunology.
[209] T. Fischer,et al. Macrophage pro-inflammatory cytokine secretion is enhanced following interaction with autologous platelets , 2010, Journal of Inflammation.
[210] M. K. Johnson,et al. Effects of pneumolysin on human polymorphonuclear leukocytes and platelets , 1981, Infection and immunity.
[211] H. L. Wright,et al. Neutrophil function in inflammation and inflammatory diseases. , 2010, Rheumatology.
[212] C. Weber,et al. Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease , 2007, Circulation research.
[213] A. Moses,et al. The influence of human immunodeficiency virus-1 on hematopoiesis. , 1998, Blood.
[214] W. Yin,et al. Platelet mediated complement activation. , 2008, Advances in Experimental Medicine and Biology.
[215] S. Aref,et al. Thrombopoietin (TPO) Levels in Hepatic Patients with Thrombocytopenia , 2004, Hematology.
[216] L. Drago,et al. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity , 2013, BMC Microbiology.
[217] C. Lass‐Flörl,et al. Platelets enhance activity of antimycotic substances against non-Aspergillus fumigatus Aspergillus species in vitro. , 2011, Medical mycology.
[218] G. Reed,et al. Molecular mechanisms of platelet exocytosis: insights into the "secrete" life of thrombocytes. , 2000, Blood.
[219] J. Dankert,et al. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis , 1995, Infection and immunity.